Belite Bio BLTE
NASDAQ BLTE
$146.90 -3.37 (-2.24%)
As of: Oct 23, 2026 · 1:22 PM EDT

Belite Bio (BLTE) Net Cash Flow (2024 - 2025)

Updated

Belite Bio's Net Cash Flow was $196 million in Q4 2025, compared with $9.16 million a year earlier.

Analysis

Belite Bio (BLTE) Net Cash Flow (2024 - 2025) Analysis & Trends

For FY2025, Net Cash Flow at Belite Bio came in at $321.14 million.

  • Net Cash Flow shows a five-year compound annual growth rate of 68.6% (FY2020 to FY2025).
  • In earlier years, Net Cash Flow was -$56.21 million in FY2024, $46.06 million in FY2023 (+83.4%), $25.11 million in FY2022 and -$8.11 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF (Qtr)
1 Eli Lilly 1,131.34 Bn 1,099.92 Bn 19.71 Bn 3.72 Bn
2 Johnson & Johnson 634.44 Bn 554.30 Bn 17.30 Bn -3.52 Bn
3 AbbVie 506.53 Bn 479.65 Bn 12.70 Bn -2.82 Bn
4 Merck 357.58 Bn 311.96 Bn 12.21 Bn 1.53 Bn
5 Novartis Ag 291.71 Bn 255.70 Bn 11.24 Bn 757.00 Mn
6 Astrazeneca 265.06 Bn 238.74 Bn 12.86 Bn -3.94 Bn
7 Amgen 238.11 Bn 193.51 Bn 7.24 Bn 1.95 Bn
8 Gilead Sciences 195.32 Bn 169.52 Bn 6.22 Bn -4.43 Bn
9 Pfizer 171.12 Bn 117.76 Bn 10.94 Bn -722.00 Mn
10 Belite Bio 4.93 Bn 4.93 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 196.00 Mn
Dec 31, 2024 9.16 Mn
API Access

Belite Bio Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=BLTE&period=max&api_key=YOUR_API_KEY